Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Walmart Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $844.0B | |
|---|---|---|
| Revenue (ttm) | 735.8B | |
| Net income (ttm) | 22.1B | |
| EPS (ttm) | $2.76 | |
| Shares out | 7.9B | |
| P/E (trailing) | 43.0x | |
| P/E (forward) | 36.8x | |
| Dividend | $0.99 (0.83%) | |
| Volume | 10,107,180 | |
| Beta | 0.58 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | Trend |
| Revenue | $567.76B | $605.88B | $642.64B | $674.54B | $706.41B | +5.6% |
| Gross profit | $143.75B | $147.57B | $157.98B | $169.23B | $177.77B | +5.5% |
| Operating income | $25.94B | $20.43B | $27.01B | $29.35B | $29.83B | +3.5% |
| Net income | $13.67B | $11.68B | $15.51B | $19.44B | $21.89B | +12.5% |
| EPS (diluted) | $1.62 | $1.42 | $1.91 | $2.41 | $2.73 | +13.9% |
| EBITDA | $31.35B | $30.09B | $36.38B | $42.01B | $46.47B | +10.3% |
| R&D | — | — | — | — | — | — |
| SG&A | $117.81B | $127.14B | $130.97B | $139.88B | $147.94B | +5.9% |
Recent company headlines from major financial publishers.
This path would allow more operating cash to become free cash flow. It fades if investment intensity remains high through FY2029 or segment margins weaken.
This path depends on meeting the FY2028 revenue and earnings estimates while preserving Walmart U.S. operating profitability. It weakens if annual Walmart U.S. revenue growth stays below 3% or operating margin stays below 4.8% for two consecutive fiscal years. Either breach would reduce consolidated sales, profit, earnings per share and free cash flow.
| Ke ↓ / g → | 2.6% | 3.1% | 3.6% | 4.1% | 4.6% |
|---|---|---|---|---|---|
| 5.7% | $97.5 | $110 | $130 | $167 | $261 |
| 6.7% | $78.7 | $84.9 | $93.2 | $105 | $124 |
| 7.7% | $67.7 | $71.2 | $75.7 | $81.5 | $89.3 |
| 8.7% | $60.3 | $62.6 | $65.3 | $68.6 | $72.8 |
| 9.7% | $55.1 | $56.6 | $58.4 | $60.5 | $63.0 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |